Continuous Tableting Lines

At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.

Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:

 

  • by collecting more information during R&D phase, in a short time with less product
  • by excluding risky, time- and product consuming scale-up exercises
  • by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
  • by incorporating flexible batch size (JIT production), reducing inventory
  • by reducing the energy cost per tablet, reducing environmental impact. 
Erhalten Sie Nachrichten von GEA

Informieren Sie sich über GEA Innovationen und Erfolgsgeschichten, indem Sie die News von GEA abonnieren.

Kontaktieren Sie uns

Wir helfen Ihnen gern weiter! Mit wenigen Details können wir Ihre Anfrage beantworten.

© GEA Group Aktiengesellschaft 2024

Cookie settings